Thermo Fisher Scientific Inc with price, financials, news flow, and insider context in one page.
Thermo Fisher Scientific Inc is being tracked here through price action, operating context, and headline flow. This public page covers the latest market move, where TMO sits inside Healthcare and Diagnostics & Research, and the key financial markers that matter before moving into a fuller research workflow.
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
This page is structured for research context, not a trade call. It gives you a clean read on where TMO sits in its range, what the last few quarters look like, and which headlines are shaping attention.
For position sizing, alerts, saved watchlists, and deeper analysis workflows, the next step is the logged-in Meridian workspace.
| Quarter | Revenue | Net income | Free cash flow |
|---|---|---|---|
| Q1 2026 | 11.01B | 1.65B | 816M |
| Q4 2025 | 12.22B | 1.96B | 2.99B |
| Q3 2025 | 11.12B | 1.62B | 1.84B |
| Q2 2025 | 10.85B | 1.62B | 1.11B |
Xbox consoles, Nintendo's new Switch 2 and Valve's Steam Deck are just some of the gadgets seeing price hikes in recent months.
The attacks come as the United States and Iran are supposed to be engaging in a 60-day ceasefire as they attempt to work toward a resolution.
Venezuela's interim President Delcy Rodriguez said on state television that 10 more countries were still to join rescue efforts.
See the next report date, earnings cadence, and reporting context.
Open a side-by-side comparison page to frame valuation and growth.
Read open desk notes tied to sectors, macro themes, and active names.
Learn the framework behind valuation, momentum, and risk before you act.
Thermo Fisher Scientific Inc (TMO) — questions investors ask
What is the current stock price of Thermo Fisher Scientific Inc (TMO)?
Thermo Fisher Scientific Inc (TMO) is trading at $513.03, up 1.44% in the latest session. The live price and one-year chart on this page update through the trading day.
What is Thermo Fisher Scientific Inc's market capitalization?
Thermo Fisher Scientific Inc has a market capitalization of about 190.65B, derived from the latest share price and shares outstanding.
When is Thermo Fisher Scientific Inc's next earnings date?
Thermo Fisher Scientific Inc is next expected to report earnings on Jul 22, 2026. The TMO earnings page tracks the estimate and reporting history.
What is Thermo Fisher Scientific Inc's P/E ratio?
Thermo Fisher Scientific Inc trades at a forward price-to-earnings ratio of 18.82 — one measure of how the market is pricing its future earnings.
What is TMO's 52-week trading range?
Over the past 52 weeks, TMO has traded between $401.45 and $643.99.
What sector is Thermo Fisher Scientific Inc in?
Thermo Fisher Scientific Inc operates in the Healthcare sector, within the Diagnostics & Research industry.
Does Thermo Fisher Scientific Inc pay a dividend?
Thermo Fisher Scientific Inc currently carries a dividend yield of about 37.0%.
What is the analyst price target for TMO?
The mean analyst price target for TMO is $596.26, with an overall analyst view of Buy.
A public stock page should answer the first research questions before asking for a signup.
This TMO page is designed for public research utility. You can read the latest session move, check the one-year chart, review a compact financial table, scan recent headlines, and compare adjacent names without immediately moving into a gated dashboard.
The logged-in Meridian workflow goes further with saved watchlists, deeper analysis, alert routing, and recurring review systems. The public layer is meant to be credible and indexable on its own, not a hollow teaser page.